Taipei, Taiwan

Wei-Chun Huangfu


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Wei-Chun Huangfu: Innovator in Cancer Detection and Treatment

Introduction

Wei-Chun Huangfu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative work on antibodies. His research focuses on the development of anti-EGF like domain multiple 6 (EGFL6) antibodies, which play a crucial role in cancer detection and treatment.

Latest Patents

Wei-Chun Huangfu holds 1 patent for his invention related to anti-EGFL6 antibodies. This invention pertains to the creation of antibodies that can bind to EGFL6, thereby inhibiting angiogenesis and cancer cell growth. The anti-EGFL6 antibodies, particularly in the form of single-chain antibody fragments (scFv) and humanized antibodies, are designed for effective cancer diagnosis and treatment.

Career Highlights

Throughout his career, Wei-Chun Huangfu has been associated with prestigious institutions such as Taipei Medical University and Changhua Christian Medical Foundation Changhua Christian Hospital. His work in these organizations has allowed him to advance his research and contribute to the medical field significantly.

Collaborations

Wei-Chun Huangfu has collaborated with notable colleagues, including Yu-Ching Lee and Shiow-Lin Pan. These collaborations have further enriched his research and development efforts in the field of cancer treatment.

Conclusion

Wei-Chun Huangfu's innovative work in developing anti-EGFL6 antibodies represents a significant advancement in cancer detection and treatment. His contributions to the medical field continue to inspire future research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…